CannTrust Holdings (NYSE:CTST,TSX:TRST) is at risk of getting bumped off the New York Stock Exchange (NYSE) because of its too-low share price, the company said in a press release.

The embattled Ontario-based cannabis firm told investors on Tuesday (December 10) it had received a notice from the exchange stating that it no longer complies with the US$1 price-per-share threshold the NYSE requires over a consecutive 30 day period to remain in line with its listing standards.


As of 3:14 p.m. EST on Wednesday (December 11), CannTrust sat at US$0.81 on the NYSE. The last time shares were above the US$1 mark was on November 11, when they closed at US$1.04.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

CannTrust said it now has six months to get its closing and average share price up to scratch for at least 30 days in a row, during which its common shares will continue to list on the NYSE.

The news comes just weeks after the Toronto Stock Exchange (TSX) said it would delist CannTrust’s TSX shares if did not receive certain financial documents by March 25, 2020, including restated interim financial statements for the first, second and third quarters of 2019.

“CannTrust anticipates filing those disclosures and meeting the TSX’s requirements before March 25, 2020. The company continues to make progress in working with its independent auditor in connection with preparing its financial statements and corresponding MD&A,” the firm said at the time.

The company has been under fire since July, when Health Canada flagged its cultivation facility in Pelham, Ontario, as non-compliant because the company was growing cannabis in unlicensed rooms and had used false walls to hide the illegal operations.

canntrust nyse stock chart

In the ensuing fallout, it was found that high-level executives, including former CEO Peter Aceto and former Chairman Eric Paul, knew about the illegal growing, which led to their departures from the firm.

In the months following the discovery, a second of CannTrust’s facilities was found to be non-compliant. Additionally, Ontario’s provincial cannabis retailer returned millions of dollars worth of CannTrust products and the company had its production license suspended by the federal regulator.

Since the initial non-compliance rating in July, CannTrust shares have plummeted almost 80 percent in New York and Toronto.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

US-based multi-state operators (MSOs) performed well during Q1, but one fund manager believes that hasn’t been reflected in their share prices.

Keep reading... Show less

 Aion Therapeutic Inc. (CSE: AION) (” Aion Therapeutic ” or the ” Company “) announced today that its proprietary and patented combinatorial mushroom preparations AION F7 and AION F8 (collectively, the ” Aion Mushroom Preparations ” or ” Preparations “) showed high efficacy in killing HER2+ breast cancer cells, ER+PR+ breast cancer cells, and triple-negative breast cancer cells by direct cytotoxicity.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) (“Nextleaf”, “OILS”, or the “Company”) , the world’s most innovative cannabis processor, is pleased to announce that its wholly-owned subsidiary Nextleaf Labs Ltd. (“Nextleaf Labs” or “Labs”) has completed an inaugural bulk CBD distillate delivery to a U.S.-listed, Canadian-based global cannabis company. The Company anticipates similar orders on an ongoing basis.

Keep reading... Show less

The Company Will Tap into Southern Glazer’s Established Distribution Network to Bring Quatreau, its CBD-Infused Sparkling Water, to U.S. Retailers

 Canopy Growth Corporation (“Canopy Growth”) (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, CBD and vaporization device company, today announced Southern Glazer’s Wine & Spirits (“Southern Glazer’s”), the world’s pre-eminent distributor of beverage alcohol, as the distribution partner for its U.S. portfolio of CBD-infused beverages. This partnership announcement follows the recent launch of Quatreau Canopy’s first line of CBD-infused beverages sold in the U.S market.

Keep reading... Show less

 Canbud Distribution Corporation (CSE: CBDX) (FSE: CD0) (“Canbud” or the “Corporation”) announces its subsidiary Empathy Plant Co. has completed the full development of its vegan multivitamin formula exclusively for women.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/7448/81051_95aa98db045cb95d_001.jpg
Unique Vegan Women’s Multi-Vitamin with 100% Compostable Packaging

Keep reading... Show less